Our study demonstrated that concentrations of IL-17F, IL-23 and IL-1b were significantly lower in patients with acute decompensation and ACLF compared to those with compensated cirrhosis, indicating a progressive decline with increasing disease severity. This evidence concerns the gene IL17F and Cirrhosis.